Cipla Limited — Important, 17-05-2025: Updates
17-05-2025 | 05:51 pm
17-05-2025 | 05:51 pm
Cipla’s wholly owned subsidiary Sitec Labs received a Voluntary Action Indicated (VAI) classification from the USFDA for minor compliance issues at its Mahape analytical testing facility. There is no significant regulatory action or direct financial impact. Cipla remains focused on upholding strong regulatory standards across its operations.
No comments yet. Be the first to comment!
